Literature DB >> 9551959

Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.

A Raziuddin1, D L Longo, L Mason, J R Ortaldo, M Bennett, W J Murphy.   

Abstract

Natural killer cells mediate the specific rejection of bone marrow cell (BMC) allografts in lethally irradiated mice. The Ly-49 family of molecules present on subsets of murine NK cells appears capable of binding class I MHC molecules, resulting in transmission of an inhibitory signal to the NK cell. These Ly-49 family members have been shown to have an immunoreceptor tyrosine-based inhibitory motif that is responsible for the inhibitory signal. However, a new Ly-49 family member was found that lacks this motif, Ly-49D, and evidence suggests that this may be an activating receptor. We therefore compared the role of the activating Ly-49 member with NK cells bearing inhibitory Ly-49 receptors in BMC rejection. Depletion of Ly-49D+ NK cells in H-2b mice abrogated their ability to reject H-2d BMC allografts. Similarly, Ly-49C+ NK cells also were shown to mediate the specific rejection of H-2d BMC. When both subsets were depleted, an additive enhancement of BMC engraftment was observed, indicating that both subsets play a role in the rejection of allogeneic H-2-homozygous H-2d BMC. However, rejection of H-2(b x d) or D8 (H-2b, Dd transgene) BMC allografts was unaffected by Ly-49C+ NK cell depletion in H-2b mice. In marked contrast, depletion of Ly-49D+ NK cells in H-2b mice totally abrogated the rejection of H-2(b x d) heterozygous BMC in support of in vitro data suggesting that Ly-49D+ NK cells receive activating signals. Therefore, NK subsets demonstrate a differential ability to reject H-2 homozygous and heterozygous BMC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551959

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  The requirement for NKG2D in NK cell-mediated rejection of parental bone marrow grafts is determined by MHC class I expressed by the graft recipient.

Authors:  Joshua N Beilke; Jonathan Benjamin; Lewis L Lanier
Journal:  Blood       Date:  2010-08-24       Impact factor: 22.113

2.  Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts.

Authors:  Kouetsu Ogasawara; Jonathan Benjamin; Rayna Takaki; Joseph H Phillips; Lewis L Lanier
Journal:  Nat Immunol       Date:  2005-08-07       Impact factor: 25.606

3.  Efficacy and limitations of natural killer cell depletion in cyclophosphamide-induced tolerance.

Authors:  Ichiro Shimizu; Yukihiro Tomita; Shinji Okano; Toshiro Iwai; Takashi Kajiwara; Tatsushi Onzuka; Ryuji Tominaga
Journal:  Surg Today       Date:  2007-01-01       Impact factor: 2.549

4.  The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing.

Authors:  A H Idris; H R Smith; L H Mason; J R Ortaldo; A A Scalzo; W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  Prenatal Allospecific NK Cell Tolerance Hinges on Instructive Allorecognition through the Activating Receptor during Development.

Authors:  Amir M Alhajjat; Beverly S Strong; Amanda E Lee; Lucas E Turner; Ram K Wadhwani; John R Ortaldo; Jonathan W Heusel; Aimen F Shaaban
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

Review 6.  DAP10- and DAP12-associated receptors in innate immunity.

Authors:  Lewis L Lanier
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

7.  Natural killer cell mediated missing-self recognition can protect mice from primary chronic myeloid leukemia in vivo.

Authors:  Mika Kijima; Noémie Gardiol; Werner Held
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

8.  The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation.

Authors:  Christine M Lin; Ronald G Gill; Borna Mehrad
Journal:  Am J Transplant       Date:  2021-06-17       Impact factor: 9.369

9.  Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I.

Authors:  Junzo Koike; Hiroshi Wakao; Yuko Ishizuka; Taka-aki Sato; Masaru Hamaoki; Ken-ichiro Seino; Haruhiko Koseki; Toshinori Nakayama; Masaru Taniguchi
Journal:  J Exp Med       Date:  2004-01-05       Impact factor: 14.307

10.  Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity.

Authors:  M C Nakamura; P A Linnemeyer; E C Niemi; L H Mason; J R Ortaldo; J C Ryan; W E Seaman
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.